Genemedi produces core diagnostic ingredients for test of Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) and related syndrome. GeneMedi offers paired diagnostics grade Serum Amyloid A1 (SAA1) antibodies (monoclonal antibody, mab) and antigens for Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis) rapid test kit of Serum Amyloid A1 (SAA1) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Inflammation/autoimmune/inflammatory disease (Inflammatory amyloidosis ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Serum amyloid A1 is made primarily in the liver and circulates in low levels in the blood. Serum amyloid A1 appears to play a role in the immune system. Serum amyloid A1 may help repair damaged tissues, act as an antibacterial agent, and signal the migration of germ-fighting cells to sites of infection. Levels of this protein increase in the blood and other tissues under conditions of inflammation. Inflammation occurs when the immune system sends signaling molecules and white blood cells to a site of injury or disease to fight microbial invaders and facilitate tissue repair. SAA1 has been a clinical indicator and reliable biomarker for inflammatory diseases, chronic metabolic disorders and late-stage malignancy. Inflammatory amyloidosis results from chronic inflammation with increased production of SAA1, which is a major precursor of amyloid A fibril deposit in various tissues.